|
2025-03-25 |
2025-03-24 |
B
Purchase
|
Wettig Thane
CEO
Executive Director
|
145,000
+36.4%
0.35
USD 50,663
|
145,000
+36.4%
|
0.35
|
USD 50,663
|
|
|
2025-03-24 |
2025-03-21 |
B
Purchase
|
Schoeneck James A
Non-Executive Director
|
50,000
+15.4%
0.34
USD 17,040
|
50,000
+15.4%
|
0.34
|
USD 17,040
|
|
|
2025-03-24 |
2025-03-20 |
B
Purchase
|
Schoeneck James A
Non-Executive Director
|
250,000
+339.1%
0.35
USD 88,000
|
250,000
+339.1%
|
0.35
|
USD 88,000
|
|
|
2024-06-13 |
2024-06-12 |
B
Purchase
|
Adib Deyaa
Chief Medical Officer
Officer
|
22,123
+36.9%
1.17
USD 25,884
|
22,123
+36.9%
|
1.17
|
USD 25,884
|
|
|
2024-03-11 |
2024-03-07 |
B
Purchase
|
Wettig Thane
CEO
Officer
|
50,000
+11.9%
1.91
USD 95,470
|
50,000
+11.9%
|
1.91
|
USD 95,470
|
|
|
2023-09-06 |
2023-09-01 |
PS
Planned sale
|
Henderson Jeffrey William
Non-Executive Director
|
2,000
-6.5%
1.03
USD 2,060
|
2,000
-6.5%
|
1.03
|
USD 2,060
|
|
|
2023-08-08 |
2023-08-04 |
PS
Planned sale
|
Henderson Jeffrey William
Non-Executive Director
|
2,000
-6.1%
1.91
USD 3,820
|
2,000
-6.1%
|
1.91
|
USD 3,820
|
|
|
2023-07-13 |
2023-07-11 |
PS
Planned sale
|
Henderson Jeffrey William
Non-Executive Director
|
2,000
-5.7%
2.69
USD 5,380
|
2,000
-5.7%
|
2.69
|
USD 5,380
|
|
|
2023-07-10 |
2023-07-07 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
1,880
-0.5%
2.80
USD 5,264
|
1,880
-0.5%
|
2.80
|
USD 5,264
|
|
|
2023-06-26 |
2023-06-23 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
791
-0.7%
16.53
USD 13,075
|
791
-0.7%
|
16.53
|
USD 13,075
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Chung Christine
SVP, China Operations
Officer
|
1,000
-0.4%
17.46
USD 17,460
|
1,000
-0.4%
|
17.46
|
USD 17,460
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Chung Christine
SVP, China Operations
Officer
|
5,250
-2.2%
16.66
USD 87,465
|
5,250
-2.2%
|
16.66
|
USD 87,465
|
|
|
2023-06-15 |
2023-06-13 |
PS
Planned sale
|
Chung Christine
SVP, China Operations
Officer
|
6,250
-2.5%
17.60
USD 110,000
|
6,250
-2.5%
|
17.60
|
USD 110,000
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Brennan Aoife
Non-Executive Director
|
2,739
-8.9%
17.52
USD 47,987
|
2,739
-8.9%
|
17.52
|
USD 47,987
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Brennan Aoife
Non-Executive Director
|
1,994
-6.1%
16.74
USD 33,380
|
1,994
-6.1%
|
16.74
|
USD 33,380
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
EDWARDS JEFFREY L
Non-Executive Director
|
4,624
-12.0%
17.51
USD 80,966
|
4,624
-12.0%
|
17.51
|
USD 80,966
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
EDWARDS JEFFREY L
Non-Executive Director
|
3,265
-7.8%
16.74
USD 54,656
|
3,265
-7.8%
|
16.74
|
USD 54,656
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Blaug Suzanne
Non-Executive Director
|
5,169
-14.9%
17.51
USD 90,509
|
5,169
-14.9%
|
17.51
|
USD 90,509
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Blaug Suzanne
Non-Executive Director
|
3,351
-8.8%
16.73
USD 56,062
|
3,351
-8.8%
|
16.73
|
USD 56,062
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Cravatt Benjamin
Non-Executive Director
|
2,178
-7.0%
17.51
USD 38,137
|
2,178
-7.0%
|
17.51
|
USD 38,137
|
|
|
2023-06-09 |
2023-06-09 |
PS
Planned sale
|
Cravatt Benjamin
Non-Executive Director
|
1,766
-5.4%
16.75
USD 29,581
|
1,766
-5.4%
|
16.75
|
USD 29,581
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
Henderson Jeffrey William
Non-Executive Director
|
4,994
-12.5%
17.69
USD 88,344
|
4,994
-12.5%
|
17.69
|
USD 88,344
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
Henderson Jeffrey William
Non-Executive Director
|
2,006
-4.8%
16.87
USD 33,841
|
2,006
-4.8%
|
16.87
|
USD 33,841
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
Ho Maykin
Non-Executive Director
|
6,225
-16.5%
17.68
USD 110,058
|
6,225
-16.5%
|
17.68
|
USD 110,058
|
|
|
2023-06-09 |
2023-06-08 |
PS
Planned sale
|
Ho Maykin
Non-Executive Director
|
2,295
-5.7%
16.79
USD 38,533
|
2,295
-5.7%
|
16.79
|
USD 38,533
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Eisner Mark
EVP, Chief Medical Officer
Officer
|
2,042
-1.2%
17.04
USD 34,792
|
2,042
-1.2%
|
17.04
|
USD 34,792
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
1,286
-1.1%
17.04
USD 21,910
|
1,286
-1.1%
|
17.04
|
USD 21,910
|
|
|
2023-06-09 |
2023-06-07 |
PS
Planned sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
472
-0.4%
17.04
USD 8,041
|
472
-0.4%
|
17.04
|
USD 8,041
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
6,106
-1.6%
17.04
USD 104,033
|
6,106
-1.6%
|
17.04
|
USD 104,033
|
|
|
2023-06-09 |
2023-06-07 |
PS
Planned sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
2,791
-0.7%
17.04
USD 47,550
|
2,791
-0.7%
|
17.04
|
USD 47,550
|
|
|
2023-06-09 |
2023-06-07 |
PS
Planned sale
|
Schoeneck James A
Non-Executive Director
|
7,100
-8.8%
18.03
USD 127,987
|
7,100
-8.8%
|
18.03
|
USD 127,987
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
735
-1.0%
17.04
USD 12,523
|
735
-1.0%
|
17.04
|
USD 12,523
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
1,050
-1.4%
16.95
USD 17,797
|
1,050
-1.4%
|
16.95
|
USD 17,797
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
1,532
-0.6%
17.04
USD 26,102
|
1,532
-0.6%
|
17.04
|
USD 26,102
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
739
-0.3%
17.04
USD 12,590
|
739
-0.3%
|
17.04
|
USD 12,590
|
|
|
2023-06-09 |
2023-06-07 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
1,362
-0.5%
17.04
USD 23,202
|
1,362
-0.5%
|
17.04
|
USD 23,202
|
|
|
2023-06-05 |
2023-06-02 |
S
Sale
|
Eisner Mark
EVP, Chief Medical Officer
Officer
|
1,090
-0.7%
18.83
USD 20,525
|
1,090
-0.7%
|
18.83
|
USD 20,525
|
|
|
2023-04-11 |
2023-04-10 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
1,869
-0.5%
19.52
USD 36,483
|
1,869
-0.5%
|
19.52
|
USD 36,483
|
|
|
2023-04-06 |
2023-04-04 |
S
Sale
|
Eisner Mark
Chief Medical Officer
Officer
|
9,182
-5.2%
18.78
USD 172,473
|
9,182
-5.2%
|
18.78
|
USD 172,473
|
|
|
2023-04-06 |
2023-04-04 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
6,590
-2.5%
18.78
USD 123,785
|
6,590
-2.5%
|
18.78
|
USD 123,785
|
|
|
2023-03-24 |
2023-03-23 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
905
-0.8%
18.71
USD 16,933
|
905
-0.8%
|
18.71
|
USD 16,933
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
2,344
-3.1%
20.20
USD 47,342
|
2,344
-3.1%
|
20.20
|
USD 47,342
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
1,456
-1.9%
20.20
USD 29,407
|
1,456
-1.9%
|
20.20
|
USD 29,407
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
1,112
-1.4%
20.20
USD 22,459
|
1,112
-1.4%
|
20.20
|
USD 22,459
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
19,486
-4.8%
20.20
USD 393,565
|
19,486
-4.8%
|
20.20
|
USD 393,565
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
12,103
-2.9%
20.20
USD 244,448
|
12,103
-2.9%
|
20.20
|
USD 244,448
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Eisner Mark
Chief Medical Officer
Officer
|
6,255
-3.4%
20.20
USD 126,334
|
6,255
-3.4%
|
20.20
|
USD 126,334
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Eisner Mark
Chief Medical Officer
Officer
|
3,885
-2.1%
20.20
USD 78,467
|
3,885
-2.1%
|
20.20
|
USD 78,467
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
4,731
-4.1%
20.20
USD 95,553
|
4,731
-4.1%
|
20.20
|
USD 95,553
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
2,938
-2.5%
20.20
USD 59,340
|
2,938
-2.5%
|
20.20
|
USD 59,340
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
2,914
-1.1%
20.20
USD 58,855
|
2,914
-1.1%
|
20.20
|
USD 58,855
|
|
|
2023-03-10 |
2023-03-10 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
4,692
-1.8%
20.20
USD 94,766
|
4,692
-1.8%
|
20.20
|
USD 94,766
|
|
|
2023-03-10 |
2023-03-08 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
2,749
-3.8%
21.16
USD 58,158
|
2,749
-3.8%
|
21.16
|
USD 58,158
|
|
|
2023-03-10 |
2023-03-08 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
24,672
-6.5%
21.16
USD 521,958
|
24,672
-6.5%
|
21.16
|
USD 521,958
|
|
|
2023-03-10 |
2023-03-08 |
S
Sale
|
Eisner Mark
Chief Medical Officer
Officer
|
7,363
-4.3%
21.16
USD 155,771
|
7,363
-4.3%
|
21.16
|
USD 155,771
|
|
|
2023-03-10 |
2023-03-08 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
6,265
-5.7%
21.16
USD 132,542
|
6,265
-5.7%
|
21.16
|
USD 132,542
|
|
|
2023-03-10 |
2023-03-08 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
8,354
-3.2%
21.16
USD 176,736
|
8,354
-3.2%
|
21.16
|
USD 176,736
|
|
|
2023-03-06 |
2023-03-02 |
S
Sale
|
Eisner Mark
Chief Medical Officer
Officer
|
1,187
-0.7%
21.87
USD 25,960
|
1,187
-0.7%
|
21.87
|
USD 25,960
|
|
|
2023-01-10 |
2023-01-06 |
PS
Planned sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
1,538
-0.5%
19.95
USD 30,683
|
1,538
-0.5%
|
19.95
|
USD 30,683
|
|
|
2022-12-28 |
2022-12-23 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
734
-0.8%
15.80
USD 11,597
|
734
-0.8%
|
15.80
|
USD 11,597
|
|
|
2022-12-14 |
2022-12-12 |
PS
Planned sale
|
Graham Juan
Chief Financial Officer
Officer
|
1,407
-2.6%
14.50
USD 20,402
|
1,407
-2.6%
|
14.50
|
USD 20,402
|
|
|
2022-12-14 |
2022-12-09 |
S
Sale
|
Graham Juan
Chief Financial Officer
Officer
|
781
-1.4%
14.90
USD 11,637
|
781
-1.4%
|
14.90
|
USD 11,637
|
|
|
2022-12-15 |
2022-12-08 |
PS
Planned sale
|
Graham Juan
Chief Financial Officer
Officer
|
478
-0.9%
15.47
USD 7,395
|
478
-0.9%
|
15.47
|
USD 7,395
|
|
|
2022-12-15 |
2022-12-08 |
PS
Planned sale
|
Graham Juan
Chief Financial Officer
Officer
|
5,263
-9.4%
14.84
USD 78,103
|
5,263
-9.4%
|
14.84
|
USD 78,103
|
|
|
2022-12-09 |
2022-12-08 |
S
Sale
|
Conterno Enrique A
Chief Executive Officer
Executive Director
|
2,543
-0.8%
15.79
USD 40,154
|
2,543
-0.8%
|
15.79
|
USD 40,154
|
|
|
2022-12-09 |
2022-12-08 |
S
Sale
|
Chung Christine
SVP, China Operations
Officer
|
1,096
-0.5%
15.79
USD 17,306
|
1,096
-0.5%
|
15.79
|
USD 17,306
|
|
|
2022-12-09 |
2022-12-08 |
S
Sale
|
Wettig Thane
Chief Commercial Officer
Officer
|
382
-0.4%
15.79
USD 6,032
|
382
-0.4%
|
15.79
|
USD 6,032
|
|
|
2021-09-17 |
2021-09-15 |
S
Sale
|
KEARNS THOMAS F JR
Non-Executive Director
|
13,100
-24.8%
11.58
USD 151,707
|
13,100
-24.8%
|
11.58
|
USD 151,707
|
|
|
2021-03-15 |
2021-03-11 |
S
Sale
|
KEARNS THOMAS F JR
Non-Executive Director
|
18,000
-10.8%
35.02
USD 630,360
|
18,000
-10.8%
|
35.02
|
USD 630,360
|
|
|
2021-02-19 |
2021-02-17 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
844
-2.5%
52.93
USD 44,673
|
844
-2.5%
|
52.93
|
USD 44,673
|
|
|
2021-02-19 |
2021-02-17 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
5,156
-13.2%
52.31
USD 269,710
|
5,156
-13.2%
|
52.31
|
USD 269,710
|
|
|
2021-01-21 |
2021-01-19 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
6,000
-15.3%
43.38
USD 260,280
|
6,000
-15.3%
|
43.38
|
USD 260,280
|
|
|
2021-01-15 |
2021-01-14 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
5,999
-15.3%
40.04
USD 240,200
|
5,999
-15.3%
|
40.04
|
USD 240,200
|
|
|
2020-12-30 |
2020-12-28 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
100
-0.3%
41.14
USD 4,114
|
100
-0.3%
|
41.14
|
USD 4,114
|
|
|
2020-12-30 |
2020-12-28 |
PS
Planned sale
|
Kurkijarvi Kalevi
Non-Executive Director
|
5,901
-15.1%
40.39
USD 238,341
|
5,901
-15.1%
|
40.39
|
USD 238,341
|
|
